The UK is a global champion for aid spending and humanitarian relief. As the Independent Commission for Aid Impact report highlights, this Government is building mutually beneficial partnerships that go wider than aid, towards the trade and business relationships that can deliver quality investment, drive growth and create the jobs that developing countries need to lift millions out of poverty. The aim is to build self-sustaining economies that can generate their own financing through increased tax revenue and private investment.<\/p>
<\/p>
This approach to international development is a key example of how the government is bringing together all our capabilities to end extreme poverty. To support this, DFID is working with other government departments to ensure all Official Development Assistance meets the requirements of the International Development Act and the Government\u2019s transparency commitment.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1559", "label" : {"_value" : "Biography information for Sir James Duddridge"} } , "answeringMemberConstituency" : {"_value" : "Rochford and Southend East"} , "answeringMemberPrinted" : {"_value" : "James Duddridge"} , "dateOfAnswer" : {"_value" : "2020-02-18", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2020-02-18T17:42:33.01Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "20"} , "answeringDeptShortName" : {"_value" : "International Development"} , "answeringDeptSortName" : {"_value" : "International Development"} , "date" : {"_value" : "2020-02-10", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Development Aid"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for International Development, with reference to the October 2019 report of The Independent Commission for Aid Impact on mutual prosperity, what steps he is taking to ensure that Official Development Assistance spending across all Departments (a) remains focused on (i) poverty alleviation, (ii) developing and least developed countries and (iii) and leaving no one behind and (b) is fully transparent and accountable.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3930", "label" : {"_value" : "Biography information for Caroline Lucas"} } , "tablingMemberConstituency" : {"_value" : "Brighton, Pavilion"} , "tablingMemberPrinted" : [{"_value" : "Caroline Lucas"} ], "uin" : "14659"} , {"_about" : "http://data.parliament.uk/resources/1177507", "AnsweringBody" : [{"_value" : "Department for International Development"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1177507/answer", "answerText" : {"_value" : "
The UK is proud to be hosting the Gavi Replenishment Conference on 3-4th<\/sup> June, to secure Gavi the funds it needs to immunise 300 million more children and save at least 7 million lives between 2021 and 2025.<\/p> <\/p> We recognise the importance of the UK\u2019s funding to Gavi; our £1.44 billion of support to Gavi between 2016-2020 has saved 1.4 million lives from vaccine-preventable diseases in 68 of the world\u2019s poorest countries. The UK\u2019s commitment to Gavi is also central to our work to end preventable deaths of mothers, new-borns and children by 2030.<\/p> <\/p> Gavi\u2019s next strategic period is critically important for the UK as we work together to improve intra-country equity and coverage. Immunisation is often a child\u2019s first point of contact with their health service. By extending routine immunisation to reach the underserved, particularly zero-dose children who have never been vaccinated, Gavi is building a foundation for stronger national health systems. The UK will also prioritise ensuring our investment in Gavi is sustainable by supporting countries to effectively transition from Gavi support to increased domestic funding.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4358", "label" : {"_value" : "Biography information for Wendy Morton"}
}
, "answeringMemberConstituency" : {"_value" : "Aldridge-Brownhills"}
, "answeringMemberPrinted" : {"_value" : "Wendy Morton"}
, "dateOfAnswer" : {"_value" : "2020-02-18", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2020-02-18T15:50:36.507Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "20"}
, "answeringDeptShortName" : {"_value" : "International Development"}
, "answeringDeptSortName" : {"_value" : "International Development"}
, "date" : {"_value" : "2020-02-10", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Gavi, the Vaccine Alliance: Finance"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for International Development, if he will allocate an adequate level of funding to Gavi, the Vaccine Alliance, to provide for stronger health systems.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1538", "label" : {"_value" : "Biography information for Rosie Cooper"}
}
, "tablingMemberConstituency" : {"_value" : "West Lancashire"}
, "tablingMemberPrinted" : [{"_value" : "Rosie Cooper"}
], "uin" : "14627"}
, {"_about" : "http://data.parliament.uk/resources/1177508", "AnsweringBody" : [{"_value" : "Department for International Development"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1177508/answer", "answerText" : {"_value" : " Achieving universal health coverage (UHC) is a UK priority and an overarching goal for DFID\u2019s contribution to Gavi, the Vaccine Alliance. The UK\u2019s £1.44 billion of support to Gavi between 2016-2020 has saved 1.4 million lives from vaccine-preventable diseases in 68 of the world\u2019s poorest countries.<\/p> <\/p> The UK is proud to be hosting the Gavi Replenishment Conference on 3-4th<\/sup> June, to secure Gavi the funds it needs to immunise 300 million more children and save at least 7 million lives between 2021 and 2025. The UK\u2019s commitment to Gavi is central to our work to end preventable deaths of mothers, new-borns and children by 2030.<\/p> <\/p> In its next strategic period, Gavi is committed to reaching every child with essential vaccines, to improve intra-country equity and coverage. Immunisation is often a child\u2019s first point of contact with their health service. By extending routine immunisation to reach the underserved, particularly zero-dose children who have never been vaccinated, Gavi is building a foundation for UHC.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4358", "label" : {"_value" : "Biography information for Wendy Morton"}
}
, "answeringMemberConstituency" : {"_value" : "Aldridge-Brownhills"}
, "answeringMemberPrinted" : {"_value" : "Wendy Morton"}
, "dateOfAnswer" : {"_value" : "2020-02-18", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2020-02-18T15:50:03.493Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "20"}
, "answeringDeptShortName" : {"_value" : "International Development"}
, "answeringDeptSortName" : {"_value" : "International Development"}
, "date" : {"_value" : "2020-02-10", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Gavi, the Vaccine Alliance"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for International Development, what discussions he has had with his international counterparts on ensuring that universal health coverage is central to the replenishment period and strategy review with Gavi, the Vaccine Alliance.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1538", "label" : {"_value" : "Biography information for Rosie Cooper"}
}
, "tablingMemberConstituency" : {"_value" : "West Lancashire"}
, "tablingMemberPrinted" : [{"_value" : "Rosie Cooper"}
], "uin" : "14628"}
, {"_about" : "http://data.parliament.uk/resources/1177068", "AnsweringBody" : [{"_value" : "Department for International Development"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1177068/answer", "answerText" : {"_value" : " DFID invests in the Private Infrastructure Development Group (PIDG) to improve access to critical infrastructure services for people in the poorest regions of Africa and Asia \u2013 in sectors such as power, communications, transport and water.<\/p> PIDG has no active investments in any fossil fuel extraction projects. PIDG does not invest in the exploration, extraction or refining of oil, natural gas or liquid petroleum gas.<\/p> In 2004, PIDG did provide one-off funding of $500,000 (£273,000) for technical assistance to the Government of Mozambique on the feasibility of establishing a coal mine in the town of Moatize in Mozambique. PIDG\u2019s strategy now rules out any investing in coal.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4044", "label" : {"_value" : "Biography information for Andrew Stephenson"}
}
, "answeringMemberConstituency" : {"_value" : "Pendle"}
, "answeringMemberPrinted" : {"_value" : "Andrew Stephenson"}
, "dateOfAnswer" : {"_value" : "2020-02-12", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2020-02-12T17:56:36.443Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "20"}
, "answeringDeptShortName" : {"_value" : "International Development"}
, "answeringDeptSortName" : {"_value" : "International Development"}
, "date" : {"_value" : "2020-02-07", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Private Infrastructure Development Group: Fossil Fuels"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for International Development, how many fossil fuel extraction projects the Department has allocated funding to through the private infrastructure development group; when funding was allocated to each of those projects; and how much funding was allocated.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4518", "label" : {"_value" : "Biography information for Tulip Siddiq"}
}
, "tablingMemberConstituency" : {"_value" : "Hampstead and Kilburn"}
, "tablingMemberPrinted" : [{"_value" : "Tulip Siddiq"}
], "uin" : "14008"}
, {"_about" : "http://data.parliament.uk/resources/1174492", "AnsweringBody" : [{"_value" : "Department for International Development"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1174492/answer", "answerText" : {"_value" : " Public investments in research and development have had significant impact across a range of diseases and have contributed to the achievement of Sustainable Development Goal 3. For instance, UK support has been instrumental in the development of Coartem Dispersible, a child-friendly antimalarial drug. More than 390 million treatments of this life-saving drug have been delivered to over 50 countries since its launch in 2009. This is very likely to have helped reduce the number of deaths from malaria. DFID support also enabled the development of the first paediatric tuberculosis (TB) medicine, which is now available in 93 countries that account for 75% of the global paediatric TB burden.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4584", "label" : {"_value" : "Biography information for Baroness Sugg"}
}
, "answeringMemberPrinted" : {"_value" : "Baroness Sugg"}
, "dateOfAnswer" : {"_value" : "2020-02-12", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2020-02-12T16:05:12.447Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "20"}
, "answeringDeptShortName" : {"_value" : "International Development"}
, "answeringDeptSortName" : {"_value" : "International Development"}
, "date" : {"_value" : "2020-01-29", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Developing Countries: Health"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask Her Majesty's Government what assessment they have made of the impact of public investments in research and development towards delivering the targets set out in Sustainable Development Goal 3 on health.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4298", "label" : {"_value" : "Biography information for Baroness Suttie"}
}
, "tablingMemberPrinted" : [{"_value" : "Baroness Suttie"}
], "uin" : "HL952"}
], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 5, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}